FDA nod for IOLCP's manufacturing plant
21 July 2015 | News | By BioSpectrum Bureau
FDA nod for IOLCP's manufacturing plant
The manufacturing facility is located in Barnala, Punjab
IOL Chemicals and Pharmaceuticals (IOLCP) has announced that the company has received establishment inspection report from the US Food and Drug Administration (USFDA) for its Ibuprofen manufacturing facility in Barnala, Punjab.
The company's manufacturing plant already hold CEP certification (certification of suitability) for its product Ibuprofen, Metformin Hydrochloride and Lamotrigine from the European Directorate for the Quality of Medicine and Healthcare (EQDM) authorities, Council of Europe, France. The said facility has also been approved by ANVISA Brazil, WHO and MOH Japan.
